Tesamorelin + Ipamorelin 20mg Peptide
Research Use Only
Get Notified When Available
This product is currently out of stock. Enter your email and we'll notify you the moment it's back.
Research Use Only
For in vitro laboratory research by qualified professionals only. Not for human or animal administration. Not intended to treat, prevent, mitigate, or cure any disease. Batch-specific Certificates of Analysis available for all products.
Research Use Only
For in vitro laboratory research by qualified professionals only. Not for human or animal administration. Not intended to treat, prevent, mitigate, or cure any disease. Batch-specific Certificates of Analysis available for all products.
Growth hormone release is governed by two opposing inputs, GHRH driving secretion and somatostatin restraining it, with ghrelin receptor agonists acting through a third pathway that both stimulates release and blunts somatostatin tone. Combining a GHRH analogue with a GHRP is the standard way to study that synergy, because the amplitude of the resulting pulse is greater than either agent produces alone. Tesamorelin is the stabilised GHRH analogue of choice for this work, and ipamorelin the most receptor-selective GHRP. This double-strength vial is the higher-concentration counterpart to the 10mg (5+5) presentation.
Frequently Bought Together
Tesamorelin 10mg + Ipamorelin 10mg (20mg)
20mg
$219 USD
Bundle & Save
$254 USD
Save $14 USD
$319 USD
Save $34 USD
$364 USD
Save $54 USD
$399 USD
Save $79 USD
Click any product above to toggle selection
Related Peptides
Related Research News
Tesamorelin vs Ipamorelin: Evidence, Uses, Risks
This article compares tesamorelin and ipamorelin based on published human evidence, highlighting what is known about their uses and risks and where direct comparative data is missing.
CJC-1295 and Ipamorelin: Human Evidence and Limits
This reference separates what human trials, animal models, and analytical chemistry show about CJC-1295 and ipamorelin from vendor marketing, assessing the strength of the human evidence base and combination-specific safety data.
CJC-1295 and Ipamorelin Dosage: Evidence and Risks
This reference reviews the evidence on CJC-1295 and ipamorelin dosing, distinguishing what controlled studies support from what remains speculative or vendor-derived.